Double Point Ventures is a venture capital firm that invests in visionary companies shaping the future of healthcare, focusing on therapeutics (small molecules, biologics, gene and cell therapies, precision medicine), diagnostics and devices (early-revenue and innovative platforms), and digital health and healthcare services (early revenue-stage cutting-edge models). They partner with innovators by providing capital, deep industry expertise, operational guidance, and a global network to accelerate company growth, investing from early-stage breakthroughs to scalable healthcare solutions. The firm is led by Co-Founders and Managing Partners Campbell Murray and Daniel Yadegar, who bring extensive experience in life sciences investing, operations, and clinical medicine.
Hardware / software
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Campbell MurrayCo-Founder & Managing Partner
- Daniel YadegarCo-Founder & Managing Partner
How to reach them
Notable investments
Synchron, Eko Health, Cleerly Health, Cerevance, iECURE, Lumos Pharma, Umoja Biopharma